John Williams
Payments from drug & device makers
Across 137 payments — averaging $77.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$6K
- Boston Scientific$1K
- Procept Biorobotics Corporation$1K
- Cook Medical LLC$246
- Sumitomo Pharma America, Inc.$190
- KARL Storz Endoscopy-america$150
- plus $646 from 12 others
What the payments were for
- Travel & lodging$5,48752%
- Food & beverage$5,15248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 71 | $6,450 |
| Boston Scientific | 13 | $1,480 |
| Procept Biorobotics Corporation | 12 | $1,476 |
| Cook Medical LLC | 8 | $246 |
| Sumitomo Pharma America, Inc. | 8 | $190 |
| KARL Storz Endoscopy-america | 1 | $150 |
| Axonics, Inc. | 2 | $127 |
| Endo USA, Inc. | 6 | $109 |
| Progenics Pharmaceuticals, Inc. | 3 | $81 |
| Urogen Pharma, Inc. | 2 | $59 |
| Teleflex LLC | 2 | $54 |
| Olympus America Inc. | 2 | $54 |
| Pfizer | 2 | $40 |
| Dendreon Pharmaceuticals LLC | 1 | $33 |
| BD | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $25 |
| Medtronic | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$5,102
- AquaBeam Robotic System$1,281
- N/A$150
- RESONANCE$121
- Axonics$115
How this compares
$10,639 in reported general payments places this provider in the 75th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 54 | $31,539 |
| Tamsulosin Hcl | 164 | $2,066 |
| Silodosin | 27 | $2,046 |
| Pentoxifylline | 56 | $1,496 |
| Finasteride | 77 | $1,110 |
| Testosterone Cypionate | 26 | $871 |
| Estradiol | 14 | $729 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 22 | $492 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $274 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $242 |
| Oxybutynin Chloride | 17 | $211 |
| Cephalexin | 21 | $142 |
| Ciprofloxacin Hcl | 23 | $121 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $59 |
| Oxycodone Hcl | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other urology in Mesa
- Rahul MehanMesa$277K
- Harpreet WadhwaMesa$45K
- Shoaib SafiullahMesa$14K
- Greggory PeiferMesa$14K
- Daniel GilbertMesa$12K
- Curtis DunsheeTucson$16M
- Mark TysonScottsdale$4.9M
- Kalpesh PatelTucson$2.3M
- Susan KalotaTucson$1.2M
- Mitchell HumphreysPhoenix$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.